Università di Bologna
(Data Parere Unico CE 22-04-2020)
-
Formazione
-
Protocolli Covid-19
- Intermediate dose enoxaparin in hospitalized patients with moderate-severe COVID19: a pilot phase II single-arm study, INHIXACOVID19 -
Intermediate dose enoxaparin in hospitalized patients with moderate-severe COVID19: a pilot phase II single-arm study, INHIXACOVID19 -
INHIXACOVID documentiSIMIT – Società Italiana di Malattie Infettive e Tropicali- Via del Romito 63/A - 59100 Prato (PO) - Partita I.V.A. e C.F. 01440750154
Certificata ISO 9001:2015
